companydata.dkcompanydata.dk

TJ Biotech Holding ApS: Financial statements 2021

CVR: 41953616

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

TJ Biotech Holding ApS (CVR 41953616) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 1,749,111 and a net result of DKK 412,666 compared with DKK 90,196 the year before. That is an increase of 23.5% compared with the year before. Equity in the 2021 report amounted to DKK 23,484,130. The solvency ratio was 95.8%. The company had 1 employee in the financial year.

Gross Profit
DKK 1,749,111
Profit/Loss
DKK 412,666
Equity
DKK 23,484,130
Total Assets
DKK 24,509,406
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021-1.7M413K23.5M1
2020-1.4M90K23.1M1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like TJ Biotech Holding ApS

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

TJ Biotech Holding ApS: The 2020 annual report is outJul 16, 2021

TJ Biotech Holding ApS has published its annual report for 2020. Gross profit came to DKK 1,416,046, and the net result was DKK 90,196.

About TJ Biotech Holding ApS

TJ Biotech Holding ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2020. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Engelbrecht Nordkild Jonassen. The company is owned by Thomas Engelbrecht Nordkild Jonassen. The company has 1 employee (2021). In 2025, the company reported a gross profit of DKK 70,424 and a net result of DKK 4,184,576 compared with DKK 667,738 the year before. Equity in the 2025 report amounted to DKK 18,607,145.

Source: annual report 2025, Danish Business Authority

Other financial years